Nitrogen-containing heteroaryl compounds and methods of user...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S141000, C546S146000, C514S307000

Reexamination Certificate

active

07629357

ABSTRACT:
The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.

REFERENCES:
patent: 3989704 (1976-11-01), Houlihan et al.
patent: 4036964 (1977-07-01), Buckle et al.
patent: 4260611 (1981-04-01), Bartmann et al.
patent: 4559403 (1985-12-01), Bruderer et al.
patent: 4584379 (1986-04-01), Wagner
patent: 4673682 (1987-06-01), Konz et al.
patent: 4822800 (1989-04-01), Faltico et al.
patent: 4952588 (1990-08-01), Glamkowski et al.
patent: 4966906 (1990-10-01), Glamkowski et al.
patent: 5620995 (1997-04-01), Weidmann et al.
patent: 5658933 (1997-08-01), Weidmann et al.
patent: 5719164 (1998-02-01), Weidmann et al.
patent: 6093730 (2000-07-01), Weidmann et al.
patent: 6319931 (2001-11-01), Kroemer et al.
patent: 6358973 (2002-03-01), Napoletano et al.
patent: 6358976 (2002-03-01), Wityak et al.
patent: 6369053 (2002-04-01), Yuan et al.
patent: 6762318 (2004-07-01), Kodra et al.
patent: 6777425 (2004-08-01), Burli et al.
patent: 6903114 (2005-06-01), Backstrom et al.
patent: 2005/0171148 (2005-08-01), Mjalli et al.
patent: 2007/0155784 (2007-07-01), Arend et al.
patent: 2007/0185159 (2007-08-01), Arend et al.
patent: 2134866 (1995-05-01), None
patent: 0650960 (1994-09-01), None
patent: 0650961 (1994-10-01), None
patent: 0911340 (1999-04-01), None
patent: A-H07-224039 (1995-08-01), None
patent: A-H07-228571 (1995-08-01), None
patent: A-H11-302257 (1999-11-01), None
patent: 96/18616 (1996-06-01), None
patent: 2001/058892 (2001-08-01), None
patent: 2002/070510 (2002-09-01), None
patent: 2002/100832 (2002-12-01), None
patent: 2002/101073 (2002-12-01), None
patent: 2003/053997 (2003-07-01), None
patent: 2004/052285 (2004-06-01), None
patent: 2004/108121 (2004-12-01), None
patent: 2004/108681 (2004-12-01), None
patent: 2005/007192 (2005-01-01), None
patent: 2005/009962 (2005-02-01), None
patent: 2005/011696 (2005-02-01), None
patent: 2005/014533 (2005-02-01), None
Sato et al. “Stability and Physicochemical Properties of Viracept Tablets”Antibiotics and Chemotherapy14(9):1589-1592 (1998)—English Translation Not Available.
Franklin, et al. “Approaches to the design of anti-fibrotic drugs” Biochem. Soc. Trans. 19(4): 812-815 (1991).
Ivan, et al. “HlFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing”,Science, 292:464-468.
Lando, et al. “Oxygen-dependent regulation of hypoxia-inducible factors by prolyl and asparaginyl hydroxylation”,Eur.J. Biochem, 270:781-790 (2003).
Richard, et al, “Nonhypoxic Pathway Mediates the Induction of Hypoxia-inducible Factor 1α in Vascular Smooth Muscle Cells”,J. Biol. Chm, 275:26765-26771 (2000).
Sandau, et al. “Induction of Hypoxia-Inducible-Factor 1 by Nitric Oxide Is Mediated via the P1 3K Pathway”Biochem. Biophys. Res. Commun., 278:263-267(2000).
Safran, et al. “HIF hydroxylation and the mammalian oxygen-sensing pathway”J. Clin. Invest.111(6):779-783 (2003).
Sodhi, et al. “MAPK and Akt Act Cooperatively but Independently on Hypoxia Inducible Factor-1α inrasV12 Unpregulation of VEGF”Biochem.Biophys. Res.Commun., 287:292-300 (2001).
Tacchini, et al. “Hepatocyte growth factor signaling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells”Carcinogenesis, 22:1363-1371(2001).
Jaakkola, P. et al., Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292(5516):468-472 (2002).
U.S. Appl. No. 12/015,275, filed Jan. 16, 2008, Arend et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Nitrogen-containing heteroaryl compounds and methods of user... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nitrogen-containing heteroaryl compounds and methods of user..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitrogen-containing heteroaryl compounds and methods of user... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4074350

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.